These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37083466)

  • 1. The
    Orgil BO; Munkhsaikhan U; Pierre JF; Li N; Xu F; Alberson NR; Johnson JN; Wetzel GT; Boukens BJD; Lu L; Towbin JA; Purevjav E
    Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H866-H880. PubMed ID: 37083466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β.
    Padrón-Barthe L; Villalba-Orero M; Gómez-Salinero JM; Domínguez F; Román M; Larrasa-Alonso J; Ortiz-Sánchez P; Martínez F; López-Olañeta M; Bonzón-Kulichenko E; Vázquez J; Martí-Gómez C; Santiago DJ; Prados B; Giovinazzo G; Gómez-Gaviro MV; Priori S; Garcia-Pavia P; Lara-Pezzi E
    Circulation; 2019 Oct; 140(14):1188-1204. PubMed ID: 31567019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systems genetics analysis defines importance of TMEM43/
    Gu Q; Xu F; Orgil BO; Khuchua Z; Munkhsaikhan U; Johnson JN; Alberson NR; Pierre JF; Black DD; Dong D; Brennan JA; Cathey BM; Efimov IR; Towbin JA; Purevjav E; Lu L
    Physiol Genomics; 2022 Jan; 54(1):22-35. PubMed ID: 34766515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMEM43 mutation p.S358L alters intercalated disc protein expression and reduces conduction velocity in arrhythmogenic right ventricular cardiomyopathy.
    Siragam V; Cui X; Masse S; Ackerley C; Aafaqi S; Strandberg L; Tropak M; Fridman MD; Nanthakumar K; Liu J; Sun Y; Su B; Wang C; Liu X; Yan Y; Mendlowitz A; Hamilton RM
    PLoS One; 2014; 9(10):e109128. PubMed ID: 25343256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant accumulation of TMEM43 accompanied by perturbed transmural gene expression in arrhythmogenic cardiomyopathy.
    Shinomiya H; Kato H; Kuramoto Y; Watanabe N; Tsuruda T; Arimura T; Miyashita Y; Miyasaka Y; Mashimo T; Takuwa A; Motooka D; Okuzaki D; Matsuoka K; Tsukamoto O; Hakui H; Yamada N; Lee JK; Kioka H; Kitakaze M; Takashima S; Sakata Y; Asano Y
    FASEB J; 2021 Nov; 35(11):e21994. PubMed ID: 34674311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Drosophila melanogaster model for TMEM43-related arrhythmogenic right ventricular cardiomyopathy type 5.
    Klinke N; Meyer H; Ratnavadivel S; Reinhardt M; Heinisch JJ; Malmendal A; Milting H; Paululat A
    Cell Mol Life Sci; 2022 Jul; 79(8):444. PubMed ID: 35869176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5.
    Dominguez F; Zorio E; Jimenez-Jaimez J; Salguero-Bodes R; Zwart R; Gonzalez-Lopez E; Molina P; Bermúdez-Jiménez F; Delgado JF; Braza-Boïls A; Bornstein B; Toquero J; Segovia J; Van Tintelen JP; Lara-Pezzi E; Garcia-Pavia P
    Heart Rhythm; 2020 Jun; 17(6):945-954. PubMed ID: 32062046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise and arrhythmic risk in TMEM43 p.S358L arrhythmogenic right ventricular cardiomyopathy.
    Paulin FL; Hodgkinson KA; MacLaughlan S; Stuckless SN; Templeton C; Shah S; Bremner H; Roberts JD; Young TL; Parfrey PS; Connors SP
    Heart Rhythm; 2020 Jul; 17(7):1159-1166. PubMed ID: 32120009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleus.
    Milting H; Klauke B; Christensen AH; Müsebeck J; Walhorn V; Grannemann S; Münnich T; Šarić T; Rasmussen TB; Jensen HK; Mogensen J; Baecker C; Romaker E; Laser KT; zu Knyphausen E; Kassner A; Gummert J; Judge DP; Connors S; Hodgkinson K; Young TL; van der Zwaag PA; van Tintelen JP; Anselmetti D
    Eur Heart J; 2015 Apr; 36(14):872-81. PubMed ID: 24598986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TMEM43-S358L mutation enhances NF-κB-TGFβ signal cascade in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Zheng G; Jiang C; Li Y; Yang D; Ma Y; Zhang B; Li X; Zhang P; Hu X; Zhao X; Du J; Lin X
    Protein Cell; 2019 Feb; 10(2):104-119. PubMed ID: 29980933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Expression of
    Zink M; Seewald A; Rohrbach M; Brodehl A; Liedtke D; Williams T; Childs SJ; Gerull B
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMEM43 mutations associated with arrhythmogenic right ventricular cardiomyopathy in non-Newfoundland populations.
    Baskin B; Skinner JR; Sanatani S; Terespolsky D; Krahn AD; Ray PN; Scherer SW; Hamilton RM
    Hum Genet; 2013 Nov; 132(11):1245-52. PubMed ID: 23812740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a TMEM43 knockout human induced pluripotent stem cell line (HDZi003-A-1) using CRISPR/Cas9.
    Ratnavadivel S; Dammeier J; Gaertner A; de Toledo MAS; Zenke M; Gummert J; Bloch Rasmussen T; Klinke N; Jürgens K; Meyer H; Paululat A; Milting H
    Stem Cell Res; 2024 Apr; 76():103354. PubMed ID: 38430734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Preventive Treatment With Enalapril Improves Cardiac Function and Delays Mortality in Mice With Arrhythmogenic Right Ventricular Cardiomyopathy Type 5.
    Domínguez F; Lalaguna L; López-Olañeta M; Villalba-Orero M; Padrón-Barthe L; Román M; Bello-Arroyo E; Briceño A; Gonzalez-Lopez E; Segovia-Cubero J; García-Pavía P; Lara-Pezzi E
    Circ Heart Fail; 2021 Sep; 14(9):e007616. PubMed ID: 34412508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological Distress and Quality of Life in Participants Undergoing Genetic Testing for Arrhythmogenic Right Ventricular Cardiomyopathy Caused by TMEM43 p.S358L: Is It Time to Offer Population-Based Genetic Screening?
    Brothers C; Etchegary H; Curtis F; Simmonds C; Houston J; Young TL; Pullman D; Mariathas HH; Connors S; Hodgkinson K
    Public Health Genomics; 2021; 24(5-6):253-260. PubMed ID: 34500452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis and evaluation of the cardiac localization of TMEM43 in arrhythmogenic right ventricular cardiomyopathy.
    Christensen AH; Andersen CB; Tybjaerg-Hansen A; Haunso S; Svendsen JH
    Clin Genet; 2011 Sep; 80(3):256-64. PubMed ID: 21214875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luma is not essential for murine cardiac development and function.
    Stroud MJ; Fang X; Zhang J; Guimarães-Camboa N; Veevers J; Dalton ND; Gu Y; Bradford WH; Peterson KL; Evans SM; Gerace L; Chen J
    Cardiovasc Res; 2018 Mar; 114(3):378-388. PubMed ID: 29040414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated JUP plakoglobin gene mutation with left ventricular fibrosis in familial arrhythmogenic right ventricular cardiomyopathy.
    Zinkovsky D; Sood MR
    J Cardiovasc Electrophysiol; 2023 Oct; 34(10):2112-2121. PubMed ID: 37717241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed Wnt/β-catenin signaling.
    Martherus R; Jain R; Takagi K; Mendsaikhan U; Turdi S; Osinska H; James JF; Kramer K; Purevjav E; Towbin JA
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H174-87. PubMed ID: 26545710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.